Immunotherapy
Immunotherapy in Mysore at Manipal Hospital Mysore harnesses the immune system to target cancer cells using checkpoint inhibitors, CAR-T cell therapy, and monoclonal antibodies for advanced melanoma, lung cancer, lymphoma, and other malignancies. Administered through infusion centres with multidisciplinary oncology teams, it offers durable responses in previously resistant tumours. As the best immunotherapy in Mysore, it delivers cutting-edge immune modulation, improving survival rates through personalised treatment protocols.
How It Works
At Manipal Hospital Mysore, immunotherapy in Mysore begins with a detailed assessment to understand how a patient’s cancer is likely to respond. Doctors study specific markers in the tumour, such as PD-L1 levels and genetic features, which help decide the most suitable treatment approach. These results guide the choice of medicines that work by helping the immune system recognise and attack cancer cells more effectively.
Some immunotherapy drugs remove the natural brakes that slow down immune cells, allowing them to fight cancer more actively. Others are designed to target specific signals that help tumours grow. In certain blood cancers, advanced treatments like CAR-T therapy may be used, where a patient’s own immune cells are collected, modified in a laboratory to better recognise cancer, and then returned to the body after careful preparation.
Patients are closely monitored throughout treatment. Doctors watch for side effects and manage them early to keep therapy safe and comfortable. Immunotherapy is often combined with chemotherapy or targeted treatments for better results. Regular scans and follow-up reviews help specialists track progress and adjust treatment plans, ensuring care remains personalised at every stage.
Didn’t find what you were looking for?
Request a CallbackBenefits
Immunotherapy in Mysore transforms cancer outcomes through durable immune-mediated tumour control at Manipal Hospital.
-
Potential complete responses lasting years post-treatment.
-
Fewer cumulative toxicities than chemotherapy regimens.
-
Effective against metastatic disease and brain metastases.
-
Combination strategies enhance response rates synergistically.
What to Expect
Pre-Treatment Evaluation
Biomarker testing, organ function assessment, infection screening; premedication protocols established.
Infusion Day
IV access, premeds, 30-60 minute infusion; continuous cardiac, respiratory monitoring first cycle.
Immediate Post-Infusion
1-2 hour observation excluding infusion reactions; discharge with symptom diary, emergency contacts.
Ongoing Monitoring
Cycles every 2-6 weeks; scans every 2-3 cycles; irAE management algorithms; response assessment.
Why Manipal?
Manipal Hospital Mysore delivers immunotherapy through a comprehensive cancer care model that brings together medical oncology, diagnostics, nursing, and supportive services. Treatment decisions are guided by biomarker testing and reviewed by multidisciplinary tumour boards to ensure the right therapy is chosen for each patient. Dedicated infusion facilities, clear monitoring protocols, and rapid management of immune-related side effects support patient safety throughout treatment. Access to advanced therapies, including cellular treatments through partner facilities, further strengthens care options. With experienced oncologists, consistent follow-up, and a patient-centred approach, Manipal Hospital Mysore remains a trusted destination for immunotherapy in Mysore.
-
Biomarker-led treatment planning
-
Dedicated oncology infusion services
-
Multidisciplinary tumour board reviews
-
Structured monitoring and side effect management
Centre of Excellence
The Immuno-Oncology Programme at Manipal Hospital Mysore integrates advanced immunotherapy approaches into comprehensive cancer care. By combining medical expertise, molecular diagnostics, and coordinated monitoring, the programme supports safe and effective use of immune-based treatments for both solid tumours and blood cancers.
Services Offered
Services include checkpoint inhibitor therapy, monoclonal antibody treatment, CAR T-cell therapy through specialised partnerships, bispecific antibodies, cytokine-based treatments, and participation in selected immunotherapy trials. Best immunotherapy in Mysore at Manipal Hospital Mysore supports treatment for melanoma, lung cancer, lymphoma, renal cancers, and other eligible malignancies.
Facilities & Services
Facilities include dedicated oncology infusion centres, advanced molecular diagnostic laboratories, pharmacovigilance systems for immune-related side effects, PET-CT imaging for treatment assessment, and collaborative CAR T-cell therapy support. These resources enable safe, precise, and closely monitored immunotherapy in Mysore at Manipal Hospital Mysore.
Frequently Asked Questions
Immunotherapy is commonly used for melanoma, lung cancer, certain lymphomas, kidney cancer, bladder cancer, and cancers with specific genetic markers.
Reactions are uncommon and usually mild. Patients are monitored closely during infusions, especially during early cycles.
These occur when the immune system affects normal organs. Early detection and prompt treatment help manage them effectively.
Scans and blood tests are used regularly. Some patients may show temporary changes before improvement, which doctors monitor carefully.
Yes. Immunotherapy is often combined with chemotherapy or targeted treatments to improve effectiveness in selected cancers.
Consult our Experts
You’re on Our Indian Website
Visit the Global site for International patient services